A new “safety shoe” developed by a company in Lehigh Valley could help combat the spread and spread of the three most dangerous infectious diseases in the United States: choleria, malaria, and tuberculosis.
The safety shoe, called the Safe Shoes, was developed by the Lehigh School of Pharmacy.
It is available in stores nationwide.
The new product comes on the heels of a report by the Centers for Disease Control and Prevention that found the United Kingdom had the third-highest rate of cholicemia in the world.
According to the report, there were 5.3 million cases of chola in England, nearly twice the rate in the U.S. The UK has the highest rate of syphilis in the EU, according to a study published last year by the British Medical Journal.
The Safe Shoes are designed to be worn for two to three hours before going to sleep.
They contain small rubber bands to protect the feet from cold.
The bands are designed in such a way that the wearer can slip the shoes on and off quickly, the company said.
The company’s founder, Rishi Srivastava, said the shoes are meant to be used for a variety of conditions, including those associated with people who have asthma, and have a tendency to get sick.
He said the Safety Shoes will be available in markets that have low air pollution, and for people with allergies.
“We’ve designed them to work with the skin,” he said.
“If the person is allergic, they’ll wear the Safety Shoe for a day and then they’ll put it on and get used to it.
If they are not allergic, then they can put it off for a week and then it’ll get used.”
Srivastavava said the company is looking at how to distribute the safety shoes in more markets.
The company has raised $200,000 in seed funding to expand its distribution network and expand the product’s availability.
He has also started an app that will allow users to track their steps and other health data to help them stay healthier.
Srivashava said his company has tested the Safety Shovel in the field, but has not yet tested its product in a lab.
He is hoping to have a safety trial completed by the end of this year, he said, but that it may take a year or more for that to happen.
Sri Lanka was one of the countries hit hardest by the pandemic, with more than 100,000 cases of the disease reported in 2016.
It also has one of Asia’s highest rates of syphilitics.
According to the U and UK health departments, there are about 10.5 million cases and 3.8 million deaths in the Middle East, South Asia and Africa.